Medical Devices: Page 10
-
Roche wins CE mark for its first CGM
The clearance positions Roche to challenge Abbott and Dexcom for the European continuous glucose monitor market.
By Nick Paul Taylor • Updated July 10, 2024 -
Pulse drops 510(k) plan for PFA device after FDA requests clinical data
Analysts said the AFib device is now unlikely to come to market before late 2026.
By Nick Paul Taylor • July 9, 2024 -
Trendline
Medical device safety in spotlight after high profile recalls
From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.
By MedTech Dive staff -
Philips recall of imaging coils tied to 12 injuries
Several models of coils used in MRI scanners were recalled due to the risk of overheating, which can cause serious burns.
By Ricky Zipp • July 9, 2024 -
Masimo offered up to $950M for consumer business
Final terms of the deal are still being discussed, and Masimo said it plans to negotiate a higher price.
By Nick Paul Taylor • July 9, 2024 -
Baxter considers sale of kidney care unit to PE firm: WSJ
Carlyle Group could reportedly pay more than $4 billion for Baxter’s Vantive business.
By Elise Reuter • July 8, 2024 -
BD to close Ireland facility, putting 170 jobs at risk
A company spokesperson said the decision follows a recent review and reflects a push to improve operational efficiency.
By Nick Paul Taylor • July 8, 2024 -
Masimo employees rally around CEO Kiani as proxy fight looms
Hundreds of healthcare engineers have joined managers to support founder and CEO Joe Kiani as he battles an activist shareholder for control of the company.
By Susan Kelly • July 3, 2024 -
Alcon buys Belkin Vision for $81M upfront
Alcon will gain access to a laser treatment for glaucoma that it plans to sell in the U.S. by the end of the year.
By Nick Paul Taylor • July 3, 2024 -
Merit Medical pays Endogastric $105M for acid reflux treatment
Merit expects the device to add around $30 million in annual sales.
By Nick Paul Taylor • July 2, 2024 -
FDA continues crackdown on plastic syringes made in China
The agency has issued import bans for four manufacturers, and multiple companies have recalled affected syringes. Check out MedTech Dive’s roundup of the news.
By Elise Reuter • July 2, 2024 -
FDA to expand total product life cycle program
Officials plan to start accepting radiological and ophthalmic medical devices into the program, designed to accelerate medtech innovation, in October.
By Nick Paul Taylor • July 2, 2024 -
Masimo COO says he’ll resign if CEO Kiani is forced out
Activist investor Politan Capital Management is attempting to remove longtime Masimo leader Joe Kiani, claiming the company lacks independent oversight.
By Susan Kelly • July 1, 2024 -
Medtech M&A may pick up after mixed start to 2024: analysts
The annual number of medtech acquisitions is on course to slump to its lowest level since 2017, according to Needham.
By Nick Paul Taylor • July 1, 2024 -
FDA walks back injury, death reports on recent Philips BiPAP recall
The agency now says 10 injuries and seven deaths are associated with the problem. The updated numbers match figures shared by Philips and are significantly below the original report.
By Elise Reuter • Updated July 11, 2024 -
Dexcom to lay off 535 employees in California
A company spokesperson said Dexcom is centralizing its U.S. manufacturing operations in Arizona and repurposing its San Diego facility.
By Ricky Zipp • June 27, 2024 -
Medtronic CFO Karen Parkhill leaving for HP
Truist analysts wrote that “there could be some investor angst until a permanent successor is announced.”
By Nick Paul Taylor • June 27, 2024 -
Zimvie mulls sale after takeover approaches: Bloomberg
Zimvie is reportedly working with an adviser to assess its options after strategic investors and industry players showed interest in a deal.
By Nick Paul Taylor • June 26, 2024 -
Abbott and Dexcom are launching the first over-the-counter CGMs. Here are 7 questions on the new tech.
Experts expect the release of new over-the-counter glucose monitors in the U.S. to fuel more widespread use of the devices.
By Elise Reuter • June 26, 2024 -
Beyond Air cut more than 20% of employees
BTIG analysts said the company’s near-term cash needs, “disappointing sales results and lack of progress on profitability metrics” are concerning.
By Nick Paul Taylor • June 26, 2024 -
Embecta touts its insulin patch pump at ADA
Embecta said its device, with a larger insulin reservoir, addresses an unmet need for people with Type 2 diabetes.
By Elise Reuter • June 25, 2024 -
Senseonics tips 365-day CGM to double 2025 sales
Senseonics is in talks with insulin pump manufacturers about integrating its implantable Eversense continuous glucose monitor with their devices.
By Nick Paul Taylor • June 25, 2024 -
Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes
At the American Diabetes Association meeting, Insulet shared study results showing improvements in blood glucose and quality of life.
By Elise Reuter • June 24, 2024 -
Cardinal Health recalls procedure kits over plastic syringes made in China
Cardinal listed more than 500 catalog numbers in its recall notice and told customers to remove and discard the syringes.
By Nick Paul Taylor • June 24, 2024 -
Orthofix’s president of global orthopedics resigns
Kimberley Elting will end her eight-year stint at the company in July, continuing Orthofix's recent trend of executive turnover.
By Nick Paul Taylor • June 24, 2024 -
Philips Respironics to end manufacturing at two Pennsylvania plants: report
Philips said it would transition operations from the two sites to a third-party manufacturer. The plan will cut 300 jobs, according to the Pittsburgh Post-Gazette.
By Elise Reuter • June 21, 2024